Contents
Overview
Next Generation Sequencing (NGS) refers to a group of high-throughput technologies that enable the rapid sequencing of large stretches of DNA or RNA. These technologies, also known as Massively Parallel Sequencing (MPS) or second-generation sequencing, have transformed the field of genomics and have numerous applications in fields such as cancer research, genetic disease diagnosis, and personalized medicine. Companies like Illumina and Thermo Fisher Scientific have developed NGS platforms that can sequence millions of DNA sequences in parallel, generating vast amounts of genomic data. Researchers like Eric Lander and David Baltimore have utilized NGS to advance our understanding of the human genome and develop new treatments for diseases.
🎵 Origins & History
The concept of Next Generation Sequencing (NGS) emerged in the late 1990s and early 2000s, with the development of technologies such as 454 Life Sciences' pyrosequencing and Solexa's sequencing by synthesis. These technologies used miniaturized and parallelized platforms to sequence millions of DNA sequences in parallel, generating vast amounts of genomic data. The National Institutes of Health (NIH) and the Wellcome Trust have played significant roles in funding NGS research and development, enabling the creation of large-scale genomic datasets like the 1000 Genomes Project.
⚙️ How It Works
NGS platforms differ in their engineering configurations and sequencing chemistry, but they all share the technical paradigm of massively parallel sequencing via spatially separated, clonally amplified DNA templates or single DNA molecules in a flow cell. This design is very different from that of Sanger sequencing, which is based on electrophoretic separation of chain-termination products produced in individual sequencing reactions. Companies like PacBio and Oxford Nanopore have developed NGS platforms that use single-molecule sequencing, allowing for longer read lengths and more accurate sequencing. Researchers like Jennifer Doudna and Emmanuelle Charpentier have utilized NGS to develop new gene editing tools like CRISPR.
🌍 Cultural Impact
The cultural impact of NGS has been significant, with the technology being used in a wide range of fields, from cancer research to genetic disease diagnosis. The American Cancer Society and the National Cancer Institute have utilized NGS to develop new cancer treatments and therapies. NGS has also enabled the development of personalized medicine, with companies like 23andMe and Illumina offering genetic testing services that allow individuals to learn more about their genetic makeup. The FDA has also played a significant role in regulating the use of NGS in clinical settings, ensuring that the technology is used safely and effectively.
🔮 Legacy & Future
The legacy and future of NGS are closely tied to the development of new technologies and applications. As the cost of sequencing continues to decrease, NGS is becoming more accessible to researchers and clinicians, enabling the development of new treatments and therapies. The National Science Foundation and the Bill and Melinda Gates Foundation have funded research into the development of new NGS technologies, such as nanopore sequencing and single-molecule sequencing. As NGS continues to evolve, it is likely to have an even greater impact on our understanding of the human genome and the development of new treatments for diseases.
Key Facts
- Year
- 2005
- Origin
- United States
- Category
- chronic-conditions
- Type
- technology
Frequently Asked Questions
What is Next Generation Sequencing (NGS)?
NGS is a group of high-throughput technologies that enable the rapid sequencing of large stretches of DNA or RNA. It has numerous applications in fields such as cancer research, genetic disease diagnosis, and personalized medicine. Companies like Illumina and Thermo Fisher Scientific have developed NGS platforms that can sequence millions of DNA sequences in parallel, generating vast amounts of genomic data. Researchers like Eric Lander and David Baltimore have utilized NGS to advance our understanding of the human genome and develop new treatments for diseases.
How does NGS work?
NGS platforms differ in their engineering configurations and sequencing chemistry, but they all share the technical paradigm of massively parallel sequencing via spatially separated, clonally amplified DNA templates or single DNA molecules in a flow cell. This design is very different from that of Sanger sequencing, which is based on electrophoretic separation of chain-termination products produced in individual sequencing reactions. Companies like PacBio and Oxford Nanopore have developed NGS platforms that use single-molecule sequencing, allowing for longer read lengths and more accurate sequencing.
What are the applications of NGS?
NGS has numerous applications in fields such as cancer research, genetic disease diagnosis, and personalized medicine. The American Cancer Society and the National Cancer Institute have utilized NGS to develop new cancer treatments and therapies. NGS has also enabled the development of personalized medicine, with companies like 23andMe and Illumina offering genetic testing services that allow individuals to learn more about their genetic makeup.
What is the future of NGS?
The future of NGS is closely tied to the development of new technologies and applications. As the cost of sequencing continues to decrease, NGS is becoming more accessible to researchers and clinicians, enabling the development of new treatments and therapies. The National Science Foundation and the Bill and Melinda Gates Foundation have funded research into the development of new NGS technologies, such as nanopore sequencing and single-molecule sequencing.
What are the challenges and limitations of NGS?
NGS has several challenges and limitations, including the high cost of sequencing, the complexity of data analysis, and the need for specialized expertise. Additionally, NGS raises ethical concerns, such as the potential for genetic discrimination and the need for informed consent. The FDA has also played a significant role in regulating the use of NGS in clinical settings, ensuring that the technology is used safely and effectively.